CQENS Technologies Inc. financial data

Industry
Pharmaceutical Preparations
Location
5550 Nicollet Avenue, Minneapolis, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
VapAria Corp (to 12/18/2019), OICco ACQUISITION IV, INC. (to 8/12/2014)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 150 % +263%
Debt-to-equity 67.4 % -43.8%
Return On Equity -337 % +17.2%
Return On Assets -201 % -8.71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.4M shares +4.48%
Common Stock, Shares, Outstanding 26.8M shares +2.5%
Entity Public Float 0 USD
Common Stock, Value, Issued 2.68K USD +2.48%
Weighted Average Number of Shares Outstanding, Basic 26.4M shares +1.23%
Weighted Average Number of Shares Outstanding, Diluted 26.4M shares +1.23%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.5M USD +32.8%
General and Administrative Expense 1.19M USD -30%
Operating Income (Loss) -10.9M USD -155%
Net Income (Loss) Attributable to Parent -10.9M USD -153%
Earnings Per Share, Basic -0.41 USD/shares -156%
Earnings Per Share, Diluted -0.41 USD/shares -156%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.6M USD +1211%
Assets, Current 4.71M USD +1093%
Property, Plant and Equipment, Net 142K USD -12.4%
Operating Lease, Right-of-Use Asset 22K USD -72.5%
Intangible Assets, Net (Excluding Goodwill) 1.39M USD +21.2%
Assets 7.43M USD +226%
Accounts Payable, Current 962K USD +823%
Accrued Liabilities, Current 279K USD +12.4%
Liabilities, Current 3.13M USD +138%
Operating Lease, Liability, Noncurrent 4.03K USD -92.8%
Liabilities 3.13M USD +134%
Accumulated Other Comprehensive Income (Loss), Net of Tax -40 USD
Retained Earnings (Accumulated Deficit) -34.8M USD -45.7%
Stockholders' Equity Attributable to Parent 4.3M USD +355%
Liabilities and Equity 7.43M USD +226%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -350K USD +49.5%
Net Cash Provided by (Used in) Financing Activities 415K USD -34.1%
Net Cash Provided by (Used in) Investing Activities -64.5K USD -12.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 26.8M shares +2.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -121K USD +87.9%
Deferred Tax Assets, Valuation Allowance 499K USD +33.1%
Operating Lease, Liability 22K USD -72.5%
Depreciation 5.04K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.71M USD -464%
Lessee, Operating Lease, Liability, to be Paid 22.2K USD -73.2%
Operating Lease, Liability, Current 22K USD -63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.7K USD -64.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.2K USD -64.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 241 USD -92%
Deferred Tax Assets, Operating Loss Carryforwards 499K USD +33.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 66.7K USD
Additional Paid in Capital 39.1M USD +57.5%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%